boosters are going to be designed just to help the very susceptible parts of the population increase their immunity. For a short term, they'll be focused on individuals who got the fiser vaccine initially. But don't be surprised if you hearo similar things coming for merderna and for johnson and johnson in the next coming weeks.
Bloomberg Businessweek Editor Joel Weber and Businessweek Technology Reporter Drake Bennett talk about Drake's Businessweek Magazine cover story about how cobalt will aid the transition of energy. Dr. Andy Pekosz, Professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, shares his thoughts on news that the FDA will authorize a third Pfizer Covid shot for certain people. Bloomberg Opinion Senior Columnist Tim O'Brien discusses his story Disney Sees New Magic Kingdom in Sports Betting. And we Drive to the Close with Doug Ciocca, CEO at Kavar Capital.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.